CD4 and COVID-19: Given the persistent T cell activation/exhaustion observed in patients who recovered from COVID-19, we aimed to investigate the CD4+ T cell–dependent response following specific or nonspecific in vitro stimulation using an ex vivo IFN-γ–based ELISpot assay.